Laparoscopic removal of pelvic retroperitoneal schwannoma
How do I Perform a Laparoscopic Removal of a Pelvic Retroperitoneal Schwannoma
University Hospital, Strasbourg, France · NCT06313411
This study looks at how well laparoscopic surgery works to remove rare tumors in the pelvis that can cause pain and pressure in patients who have had treatment for pelvic cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital, Strasbourg, France (other) |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT06313411 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the laparoscopic removal of retroperitoneal schwannomas, which are rare benign tumors that can cause significant pelvic pain and organ compression. The study aims to gather data on surgical techniques and outcomes for patients suffering from symptomatic deep pelvic endometriosis who have undergone treatment for retroperitoneal pelvic carcinoma. By analyzing surgical approaches and patient outcomes, the study seeks to enhance the skills necessary for optimal surgical care in these complex cases.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients aged 18 and older with symptomatic deep pelvic endometriosis who have received treatment for retroperitoneal pelvic carcinoma at the Strasbourg University Hospital.
Not a fit: Patients who have expressed opposition to participating in the study will not benefit from this research.
Why it matters
Potential benefit: If successful, this study could improve surgical techniques and outcomes for patients with pelvic retroperitoneal schwannomas.
How similar studies have performed: While this specific approach is less common, similar studies on surgical techniques for rare tumors have shown promising outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patient (≥18 years old) * suffering from symptomatic deep pelvic endometriosis * having received treatment at the Strasbourg University Hospital during 2021 for a retro-peritoneal pelvic carcinoma * having not expressed, after information, the reuse of their data for the purposes of this research. Exclusion Criteria: * Patient who expressed her opposition to participating in the study
Where this trial is running
Strasbourg
- Service de Gynécologie Obstétrique - CHU de Strasbourg - France — Strasbourg, France (RECRUITING)
Study contacts
- Study coordinator: Emilie FALLER, MD
- Email: emilie.faller@chru-strasbourg.fr
- Phone: 33 3 88 12 63 87
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Endometriosis Pelvic, Schwannomas